AVIR

Atea Pharmaceuticals, Inc. - common stock (AVIR)

About Atea Pharmaceuticals, Inc. - common stock (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$5.52

Daily low

$5.32

Price at open

$5.36

52 Week High

$6.45

52 Week Low

$2.78

Market cap

427.5M

Dividend yield

Volume

440,095

Avg. volume

260,180

P/E ratio

-2.55

Atea Pharmaceuticals, Inc. - common stock News